基本信息
views: 165
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
The long-term goal of the Laboratory of Cancer Immunobiology, led by Hong-Ming Hu, Ph.D., is to understand how the immune system senses tumor cells and develop effective cancer vaccines and immunotherapy strategies. The therapeutic cancer vaccine requires activation and expansion of therapeutic effector T cells in vivo to levels above the threshold required for tumor eradication and prevention of recurrence in tumor-bearing hosts. For most bacterial and viral infections, the robust innate and adaptive immune responses generally result in control of infection and development of a strong memory response. In contrast, for patients with cancer, the host immune system often fails to control the growth of cancer despite the fact that tumor cells replicate at a much slower rate than bacteria and viruses.
The major differences between the immunology of infection and tumors include the following: tumor cells lack strong antigens and, as compared to infections, tumor cells are sensed differently by innate immune system, which orchestrates the subsequent adaptive immune response. The Laboratory of Cancer Immunobiology investigates how tumor cells, live or dead, are sensed by innate immunity and how tumor antigens are cross-presented by host professional antigen presenting cells. Better understanding the mechanisms of early stage of immune recognition of tumor cells would lead to design novel cancer vaccines and immunotherapy strategies.
The major differences between the immunology of infection and tumors include the following: tumor cells lack strong antigens and, as compared to infections, tumor cells are sensed differently by innate immune system, which orchestrates the subsequent adaptive immune response. The Laboratory of Cancer Immunobiology investigates how tumor cells, live or dead, are sensed by innate immunity and how tumor antigens are cross-presented by host professional antigen presenting cells. Better understanding the mechanisms of early stage of immune recognition of tumor cells would lead to design novel cancer vaccines and immunotherapy strategies.
Research Interests
Papers共 1943 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Physical review lettersno. 16 (2024): 161901-161901
PHYSICAL REVIEW LETTERSno. 13 (2024)
PHYSICAL REVIEW Dno. 3 (2024)
Journal of High Energy Physicsno. 5 (2024): 1-23
arxiv(2024)
Cited0Views0Bibtex
0
0
Journal of High Energy Physicsno. 5 (2024): 1-16
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn